Cover Image
市場調查報告書

冠狀動脈導線—:開發中產品分析

Coronary Guidewires - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 335331
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈導線—:開發中產品分析 Coronary Guidewires - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年11月01日 內容資訊: 英文 82 Pages
簡介

本報告提供現在正在開發的冠狀動脈導線—的開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 冠狀動脈導線—概要

第3章 開發中的產品

  • 冠狀動脈導線— - 開發中產品:各開發階段
  • 冠狀動脈導線— - 開發中產品:各地區
  • 冠狀動脈導線— - 開發中產品:各法規途徑
  • 冠狀動脈導線— - 開發中產品:各核准時期 (預定)
  • 冠狀動脈導線— - 進行中的臨床實驗

第4章 冠狀動脈導線—:正在開發的開發中產品 (各企業)

  • 冠狀動脈導線—企業 - 開發中產品:各開發階段
  • 冠狀動脈導線— - 開發中產品:各開發階段

第5章 冠狀動脈導線—企業與產品概要

  • Boston Scientific Corporation
  • Computer Vision Systems Laboratories Corp.
  • Guided Interventions LLC
  • MaRVis Technologies GmbH
  • MicroPort Scientific Corporation
  • Occlutech International AB
  • Opsens Inc.
  • The Cleveland Clinic Foundation

第6章 冠狀動脈導線—:最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0236EPD

GlobalData's Medical Devices sector report, "Coronary Guidewires - Medical Devices Pipeline Assessment, 2016" provides an overview of Coronary Guidewires currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Guidewires under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Guidewires under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Coronary Guidewires Overview

3. Products under Development

  • 3.1. Coronary Guidewires - Pipeline Products by Stage of Development
  • 3.2. Coronary Guidewires - Pipeline Products by Territory
  • 3.3. Coronary Guidewires - Pipeline Products by Regulatory Path
  • 3.4. Coronary Guidewires - Pipeline Products by Estimated Approval Date

4. Coronary Guidewires - Pipeline Products under Development by Companies

  • 4.1. Coronary Guidewires Companies - Pipeline Products by Stage of Development
  • 4.2. Coronary Guidewires - Pipeline Products by Stage of Development

5. Coronary Guidewires Companies and Product Overview

  • 5.1. Bioscan Technologies Inc. Company Overview
    • 5.1.1. Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Blueacre Technology Limited Company Overview
    • 5.2.1. Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston Scientific Corporation Company Overview
    • 5.3.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CardioSert Ltd. Company Overview
    • 5.4.1. CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. CVSL Inc. Company Overview
    • 5.5.1. CVSL Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. ENDOMATERIALS Company Overview
    • 5.6.1. ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Georgia Institute of Technology Company Overview
    • 5.7.1. Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Guided Interventions LLC Company Overview
    • 5.8.1. Guided Interventions LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. MaRVis Technologies GmbH Company Overview
    • 5.9.1. MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. MicroPort Scientific Corporation Company Overview
    • 5.10.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Occlutech International AB Company Overview
    • 5.11.1. Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. OVALUM Ltd. Company Overview
    • 5.12.1. OVALUM Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. St. Jude Medical, Inc. Company Overview
    • 5.13.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Terumo Corporation Company Overview
    • 5.14.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. The Cleveland Clinic Foundation Company Overview
    • 5.15.1. The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. University of Illinois at Chicago Company Overview
    • 5.16.1. University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Vasostar Ltd. Company Overview
    • 5.17.1. Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Coronary Guidewires- Recent Developments

  • 6.1. Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products
  • 6.2. Oct 10, 2016: St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
  • 6.3. Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
  • 6.4. Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results
  • 6.5. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.6. Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China
  • 6.7. Aug 30, 2016: MPSC Announces 2016 Interim Results
  • 6.8. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.9. Aug 01, 2016: AngioDynamics to Raise Funds through Public Offering of Shares
  • 6.10. Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
  • 6.11. Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
  • 6.12. Jul 26, 2016: Merit Medical Announces Appointment of New Director
  • 6.13. Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer
  • 6.14. Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
  • 6.15. Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.16. Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
  • 6.17. Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results
  • 6.18. Jul 05, 2016: Opsens Announces Fiscal 2016 Third Quarter Results - Sales Of $2,125,000, Up 156% Year-Over-Year
  • 6.19. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.20. Jun 22, 2016: Opsens receives Health Canada approval for the sale of OptoWire II
  • 6.21. Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
  • 6.22. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.23. Jun 03, 2016: LEPUCARE established in India
  • 6.24. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.25. May 19, 2016: New Data Presented at EuroPCR 2016 Adds to the Growing Body of Clinical Evidence Supporting St. Jude Medical FFR Technology and LAA Closure
  • 6.26. May 18, 2016: St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
  • 6.27. May 17, 2016: Opsens Raises USD3.9 Million in Private Placement of Units
  • 6.28. Apr 28, 2016: Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016
  • 6.29. Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016
  • 6.30. Apr 20, 2016: Abbott Reports First-Quarter 2016 Results
  • 6.31. Apr 19, 2016: Opsens announces results for its second quarter 2016
  • 6.32. Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results
  • 6.33. Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device
  • 6.34. Mar 16, 2016: Opsens Receives Fda 510(K) Clearance For The Optowire II
  • 6.35. Mar 08, 2016: MicroPort Angiography Guidewire Obtains CFDA Registration Certificate
  • 6.36. Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors
  • 6.37. Feb 23, 2016: Lepu Medical Amends Private Placement of Shares for USD110 Million
  • 6.38. Feb 22, 2016: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2015
  • 6.39. Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015
  • 6.40. Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence
  • 6.41. Dec 22, 2015: Opsens Raises Funds in Private Placement of Units
  • 6.42. Dec 03, 2015: Opsens Raises USD3.8 Million in Public Offering of Units
  • 6.43. Nov 27, 2015: FDA Identifies Boston Scientific's Recall Of RotaWire Elite Core Wires As Class I
  • 6.44. Nov 26, 2015: OPSENS granted approval to sell Optowire II in Japan
  • 6.45. Nov 12, 2015: OPSENS granted approval to sell OptoWire II in Europe
  • 6.46. Nov 11, 2015: Opsens announces first use of its FFR products in the United States
  • 6.47. Nov 06, 2015: Merit Medical Names New Chief Financial Officer
  • 6.48. Oct 28, 2015: OPSENS performs 1,000th procedure with the Optowire
  • 6.49. Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015
  • 6.50. Oct 27, 2015: BIOTRONIK Announces European Launch of New Generation of Galeo Coronary Guide Wires

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Coronary Guidewires - Pipeline Products by Stage of Development
  • Table 2: Coronary Guidewires - Pipeline Products by Territory
  • Table 3: Coronary Guidewires - Pipeline Products by Regulatory Path
  • Table 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date
  • Table 5: Coronary Guidewires Companies - Pipeline Products by Stage of Development
  • Table 6: Coronary Guidewires - Pipeline Products by Stage of Development
  • Table 7: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Lightwire - Product Status
  • Table 9: Lightwire - Product Description
  • Table 10: Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Next Generation Guide Wire - Product Status
  • Table 12: Next Generation Guide Wire - Product Description
  • Table 13: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Crossing Wire - Product Status
  • Table 15: Crossing Wire - Product Description
  • Table 16: CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Versatile Guidewire - Product Status
  • Table 18: Versatile Guidewire - Product Description
  • Table 19: CVSL Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Maneuverable Coiled Guidewire - Product Status
  • Table 21: Maneuverable Coiled Guidewire - Product Description
  • Table 22: Steerable Guidewire - Product Status
  • Table 23: Steerable Guidewire - Product Description
  • Table 24: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Multimodal Sensing Guidewire - Product Status
  • Table 26: Multimodal Sensing Guidewire - Product Description
  • Table 27: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Intravascular Ultrasound Imaging Guidewire - Product Status
  • Table 29: Intravascular Ultrasound Imaging Guidewire - Product Description
  • Table 30: Guided Interventions LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Pressure Sensing Coronary Artery Guide Wire - Product Status
  • Table 32: Pressure Sensing Coronary Artery Guide Wire - Product Description
  • Table 33: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: MaRVis 0.014" Micro Guidewire - Product Status
  • Table 35: MaRVis 0.014" Micro Guidewire - Product Description
  • Table 36: MaRVis 0.035" Standard And Stiff Guidewire - Product Status
  • Table 37: MaRVis 0.035" Standard And Stiff Guidewire - Product Description
  • Table 38: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Micro-Guide Wire - Product Status
  • Table 40: Micro-Guide Wire - Product Description
  • Table 41: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Occlutech Stiff Guide Wire - Product Status
  • Table 43: Occlutech Stiff Guide Wire - Product Description
  • Table 44: OVALUM Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: OctoBooster Extension Guidewire - Product Status
  • Table 46: OctoBooster Extension Guidewire - Product Description
  • Table 47: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Sensor Enabled - Quadra Excel Guidewire - Product Status
  • Table 49: Sensor Enabled - Quadra Excel Guidewire - Product Description
  • Table 50: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Wrist Artery Guidewire - Product Status
  • Table 52: Wrist Artery Guidewire - Product Description
  • Table 53: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: CTO Guidewire - Product Status
  • Table 55: CTO Guidewire - Product Description
  • Table 56: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: CTO Wire - Product Status
  • Table 58: CTO Wire - Product Description
  • Table 59: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Vibrational Guidewire System - Product Status
  • Table 61: Vibrational Guidewire System - Product Description
  • Table 62: Glossary

List of Figures

  • Figure 1: Coronary Guidewires - Pipeline Products by Stage of Development
  • Figure 2: Coronary Guidewires - Pipeline Products by Territory
  • Figure 3: Coronary Guidewires - Pipeline Products by Regulatory Path
  • Figure 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date
Back to Top